|
Sign In to gain access to subscriptions and/or personal tools.
|
Multiple Sclerosis, Vol. 6, No. 5,
332-337 (2000)
DOI: 10.1177/135245850000600507
© 2000 SAGE Publications
A longitudinal study of ventricular volume in early relapsing-remitting multiple sclerosis
T L Luks
Department of Radiology, University of California at San Francisco, AC-109, 1 Irving St, San Francisco, California, CA 94143, USA
D E Goodkin
UCSF/Mt. Zion Multiple Sclerosis Center, 1710 Divisadero Street, San Francisco, California, CA 94115, USA
S J Nelson
Department of Radiology, University of California at San Francisco, AC-109, 1 Irving St, San Francisco, California, CA 94143, USA
S Majumdar
Department of Radiology, University of California at San Francisco, AC-109, 1 Irving St, San Francisco, California, CA 94143, USA
P Bacchetti
Department of Biostatistics and Epidemiology, University of California at San Francisco, 500 Parnasus Ave. 420 MU-W, California, CA 94143, USA
D Portnoy
Department of Radiology, University of California at San Francisco, AC-109, 1 Irving St, San Francisco, California, CA 94143, USA
R Sloan
Department of Radiology, University of California at San Francisco, AC-109, 1 Irving St, San Francisco, California, CA 94143, USA
The specific aim of this study was to determine whether progressive brain atrophy could be detected within 18 months of establishing a diagnosis of relapsing-remitting multiple sclerosis (RRMS). Fifteen patients with clinically definite RRMS (mean disease duration from first symptom=6 months, mean EDSS=1.2) completed 6-14 monthly quantitative MRI sessions. The volume of the lateral ventricles was determined each month using a semi-automated thresholding technique from T1-weighted axial images. The number of new monthly gadolinium-enhancing (Gd+) lesions and EDSS scores were also recorded. Lateral ventricular volumes increased significantly during this study. When individual data were examined, statistically significant changes were observed in six of 15 patients. Monthly change in ventricular volume was related to baseline EDSS and total number of new Gd+ lesions. These observations indicate brain atrophy, a putative imaging marker of diffuse demyelination and axonal loss, can occur as early as 18 months after first symptons of RRMS, and is related to the baseline level of disability and to the number of new Gd+ lesions.
Key Words: multiple sclerosis atrophy MRI ventricular volume

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J H Simon
Brain atrophy in multiple sclerosis: what we know and would like to know
Multiple Sclerosis,
November 1, 2006;
12(6):
679 - 687.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
N. D. Richert, T. Howard, J. A. Frank, R. Stone, J. Ostuni, J. Ohayon, C. Bash, and H. F. McFarland
Relationship between inflammatory lesions and cerebral atrophy in multiple sclerosis
Neurology,
February 28, 2006;
66(4):
551 - 556.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Versijpt, J C Debruyne, K J Van Laere, F De Vos, J Keppens, K Strijckmans, E Achten, G Slegers, R A Dierckx, J Korf, et al.
Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study
Multiple Sclerosis,
April 1, 2005;
11(2):
127 - 134.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Pagani, M. A. Rocca, A. Gallo, M. Rovaris, V. Martinelli, G. Comi, and M. Filippi
Regional Brain Atrophy Evolves Differently in Patients with Multiple Sclerosis According to Clinical Phenotype
AJNR Am. J. Neuroradiol.,
February 1, 2005;
26(2):
341 - 346.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D T Chard, C M Griffin, W Rashid, G R Davies, D R Altmann, R Kapoor, G J Barker, A J Thompson, and D H Miller
Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis
Multiple Sclerosis,
August 1, 2004;
10(4):
387 - 391.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hardmeier, S. Wagenpfeil, P. Freitag, E. Fisher, R. A. Rudick, M. Kooijmans-Coutinho, M. Clanet, E. W. Radue, and L. Kappos
Atrophy Is Detectable Within a 3-Month Period in Untreated Patients With Active Relapsing Remitting Multiple Sclerosis
Arch Neurol,
December 1, 2003;
60(12):
1736 - 1739.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Rudick
Mechanisms of disability progression in primary progressive multiple sclerosis: are they different from secondary progressive multiple sclerosis?
Multiple Sclerosis,
April 1, 2003;
9(2):
210 - 212.
[PDF]
|
 |
|

|
 |

|
 |
 
B. Turner, X. Lin, G. Calmon, N. Roberts, and L. D Blumhardt
C erebral atrophy and disability in relapsing-remitting and secondary progressive multiple sclerosis over four years
Multiple Sclerosis,
February 1, 2003;
9(1):
21 - 27.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
E L. Hoogervorst, C H Polman, and F Barkhof
Cerebral volume changes in multiple sclerosis patients treated with high-dose intravenous methylprednisolone
Multiple Sclerosis,
October 1, 2002;
8(5):
415 - 419.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R Leigh, J Ostuni, D Pham, A Goldszal, B K Lewis, T Howard, N Richert, H McFarland, and J A Frank
Estimating cerebral atrophy in multiple sclerosis patients from various MR pulse sequences
Multiple Sclerosis,
October 1, 2002;
8(5):
420 - 429.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
N. De Stefano, S. Narayanan, S. J. Francis, S. Smith, M. Mortilla, M. C. Tartaglia, M. L. Bartolozzi, L. Guidi, A. Federico, and D. L. Arnold
Diffuse Axonal and Tissue Injury in Patients With Multiple Sclerosis With Low Cerebral Lesion Load and No Disability
Arch Neurol,
October 1, 2002;
59(10):
1565 - 1571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. T. Chard, C. M. Griffin, G. J. M. Parker, R. Kapoor, A. J. Thompson, and D. H. Miller
Brain atrophy in clinically early relapsing-remitting multiple sclerosis
Brain,
February 1, 2002;
125(2):
327 - 337.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|